Archive


Category: AmerisourceBergen

  • J&J, wholesalers see an end to their opioid liability hangover

    Johnson & Johnson and the ‘big three’ US pharm wholesalers say they are close to finalising a $26 billion settlement that could allow them to finally put years of litigation over their role in fuelling the opioid crisis behind them. The settlement is the largest to date among thousands of opioid-related lawsuits brought against pharma […]

  • The US biosimilar market: Predictions for 2021

    It has been five years since the first biosimilar launched in United States market—marking the first steps in expanding access to innovative biologic-based treatments that help patients manage and treat difficult illnesses such as cancer, rheumatoid arthritis, and other life-altering diseases. As we’ve seen over those five years, biosimilars are critical in continuing to provide […]

  • AmerisourceBergen buys Walgreens Boots Alliance wholesaling business for $6.5bn

    US wholesale giant AmerisourceBergen is to buy the majority of Walgreens Boots Alliance’s wholesaling business for around $6.5 billion in a cash and shares deal. AmerisourceBergen will pay $6.275 billion in cash and around 2 million shares of its common stock for Alliance Healthcare in a deal to support its global distribution business. Alliance will […]